1. Home
  2. LCID vs TARS Comparison

LCID vs TARS Comparison

Compare LCID & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lucid Group Inc.

LCID

Lucid Group Inc.

N/A

Current Price

$4.19

Market Cap

3.2B

ML Signal

N/A

Logo Tarsus Pharmaceuticals Inc.

TARS

Tarsus Pharmaceuticals Inc.

N/A

Current Price

$75.86

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LCID
TARS
Founded
2007
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.6B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
LCID
TARS
Price
$4.19
$75.86
Analyst Decision
Hold
Strong Buy
Analyst Count
11
10
Target Price
$7.94
★ $99.50
AVG Volume (30 Days)
★ 9.3M
615.8K
Earning Date
11-04-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 48.21
EPS
N/A
★ N/A
Revenue
★ $595,271,000.00
$451,360,000.00
Revenue This Year
$20.85
$59.75
Revenue Next Year
$121.41
$28.60
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 146.71
52 Week Low
$2.37
$53.89
52 Week High
$25.22
$91.53

Technical Indicators

Market Signals
Indicator
LCID
TARS
Relative Strength Index (RSI) 39.89 56.70
Support Level $3.99 $60.95
Resistance Level $4.55 $79.10
Average True Range (ATR) 0.21 2.35
MACD 0.07 -0.51
Stochastic Oscillator 44.60 80.38

Price Performance

Historical Comparison
LCID
TARS

About LCID Lucid Group Inc.

Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It offers its own geographically distributed retail and service locations through direct-to-consumer online and retail sales. It also boasts a product roadmap of future vehicle programs and technologies. It focuses on in-house hardware and software innovation, vertical integration, and a clean-sheet approach to engineering and design, which led to the development of the Lucid Air. The Lucid Air is a luxury sedan that redefines both the luxury car segment and the EV space. Its geographic segments include North America, the Middle East, and Other International.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.

Share on Social Networks: